Institutional investors purchased a net $5.4 million shares of OPK during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 20.97% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TRELLUS MANAGEMENT CO. LLC Bought 68.0 Thousand shares of OPKO Health Inc
DAVENPORT & CO. LLC Bought 39.0 Thousand shares of OPKO Health Inc
HOWARD CAPITAL MANAGEMENT, INC. ... Bought 20.0 Thousand shares of OPKO Health Inc